Icaritin enhances the efficacy of cetuximab against triple‑negative breast cancer cells-Reference-Cited by-同舟云学术

Icaritin enhances the efficacy of cetuximab against triple‑negative breast cancer cells

Published:2020-03-31 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Yin Li¹,Qi Xiao‑Wei²,Liu Xun‑Zhou³,Yang Ze‑Yu¹,Cai Rui‑Li¹,Cui Hong‑Juan³,Chen Li²,Yu Shi‑Cang¹

Affiliation:

1. Department of Stem Cell and Regenerative Medicine, Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China

2. Breast Disease Center, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China

3. State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400715, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyaluronic acid-modified liposomes Potentiated in-vivo anti-hepatocellular carcinoma of icaritin;Frontiers in Pharmacology;2024-07-11

2. In Vitro evaluation of the anti-pancreatic cancer activity of epimedium herb;Frontiers in Pharmacology;2024-07-01

3. Phytoactive Molecules and Nanodelivery Approaches for Breast Cancer Treatment: Current and Future Perspectives;Current Pharmaceutical Biotechnology;2024-06-07

4. Expression Significance of Estrogen Receptor ER-α36 in Breast Cancer Treated by Chemotherapy: A Meta-Analysis;Molecular Biotechnology;2024-01-25

5. Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer;Biomedicine & Pharmacotherapy;2023-06